Author Archive
Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to assess in daily practice conditions,...
LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED HYALURONIC ACID (HAppyMini®) IN TRAPEZIOMETACARPIAL...
Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Bard, D. Baron, P. Richette, T. Conrozier. Cartilage. February-01-2017. Doi: 10.1177/1947603517693043 The paper « Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering...
Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. The study « Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis », published in Journal of Orthopaedic Research this month, has been designed to identify clinical and radiological factors associated with lack of...
Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62  (36-87) BMI 25,4 (17,9-41,8) 1 injection of HANOX-M-XL(HAppyCross®) under...